![Biagio Ricciuti: If you are at AACR24, stop by poster 21 (section 1) to learn more about the discovery of ALK-specific TCR clonotypes](https://oncodaily.com/pub/uploads/2024/04/9-e1712591651552.jpeg)
Photo from Biagio Ricciuti/X
Apr 9, 2024, 13:33
Biagio Ricciuti: If you are at AACR24, stop by poster 21 (section 1) to learn more about the discovery of ALK-specific TCR clonotypes
Biagio Ricciuti, Medical Oncologist at Dana-Farber Cancer Institute, shared on X/Twitter:
”If you are at AACR24, stop by poster 21 (section 1) to learn more about the discovery of ALK-specific TCR clonotypes for the development of TCR-T cell therapies against ALK-positive cancers! Amazing study led by Carmen Mecca.”
Source: Biagio Ricciuti/X